Skip to main content

Table 3 Risk factors and co-morbid conditions at baseline

From: Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline

  Total (n = 3,810) Men (n = 2,033) Women (n = 1,777) OR (95%CI) p-value
Smoker 11.9 14.4 9.1 1.69 (1.37-2.08) < 0.0001
Any alcohol, even rare 62.9 79.9 43.6 5.15 (4.38-6.06) < 0.0001
Any Sports, even rare 40.1 45.0 34.6 1.55 (1.35-1.78) < 0.0001
Dyslipidemia 63.3 64.7 61.6 1.14 (1.00-1.31) < 0.05
Hypertension 84.4 83.6 85.3 0.88 (0.74-1.05) n.s.
Malignancy 2.0 1.8 2.2 0.83 (0.52-1.30) n.s.
Coronary artery disease 17.9 23.4 11.7 2.31 (1.93-2.76) < 0.0001
   Prior MI 34.4 38.9 24.1 2.00 (1.38-2.92) < 0.001
Prior stroke/TIA 4.6 5.0 4.2 1.18 (0.87-1.60) n.s.
PAD 6.0 7.7 4.1 1.95 (1.46-2.60) < 0.0001
Amputation* 0.9 1.2 0.6 2.20 (1.05-4.60) < 0.05
Heart failure 9.9 10.4 9.3 1.13 (0.91-1.40) n.s.
Autonomous neuropathy 3.4 3.7 2.9 1.28 (0.89-1.84) n.s.
Symptoms of peripheral neuropathy 14.4 15.7 12.8 1.27 (1.06-1.53) < 0.05
NPDR 3.8 3.6 3.9 0.91 (0.65-1.28) n.s.
PDR 0.5 0.5 0.5 0.97 (0.39-2.40) n.s.
Blindness 0.2 0.2 0.2 1.17 (0.26-5.22) n.s.
Clinically relevant depression 5.4 3.6 7.4 0.47 (0.35-0.63) < 0.0001
  1. PDR, proliferative diabetic retinopathy; MI, Myocardial Infarction; NPDR, non-proliferative diabetic retinopathy; PAD, peripheral arterial disease; TIA, transitory ischemic attack; OR, odds ratio; CI, confidence interval; * toe, foot or lower extremity